Adverum Biotechnologies, Inc. (ADVM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 0.8283 |
| Open | 0.8450 |
| Bid | 0.8448 x 1200 |
| Ask | 0.8800 x 1100 |
| Day's range | 0.8300 - 0.8999 |
| 52-week range | 0.7950 - 3.8600 |
| Volume | |
| Avg. volume | 1,097,306 |
| Market cap | 81.79M |
| Beta (5Y monthly) | 1.21 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5200 |
| Earnings date | 28 Feb 2022 - 04 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.33 |
- Simply Wall St.
How Much Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Do Institutions Own?
A look at the shareholders of Adverum Biotechnologies, Inc. ( NASDAQ:ADVM ) can tell us which group is most powerful...
- Zacks
Adverum (ADVM) Up on FDA Feedback for Gene Therapy Study
Adverum (ADVM) to submit IND amendment to the FDA by mid-2022 for starting a mid-stage study on its gene therapy candidate ADVM-022 for treating wet AMD eye disorder.
- Zacks
Should You Buy Adverum Biotechnologies (ADVM) Ahead of Earnings?
Adverum Biotechnologies (ADVM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
© 2022 Yahoo. All rights reserved.
